Americana Partners, LLC Genmab A/S Transaction History

Americana Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$26.83 - $38.57 $478,674 - $688,127	-17,841 Closed	0 $0
Q1 2022 May 06, 2022	BUY	$30.95 - $39.68 $552,178 - $707,930	17,841 New	17,841 $0
Q1 2020 May 12, 2020	SELL	$17.15 - $25.22 $17,458 - $25,673	-1,018 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$18.88 - $24.14 $19,219 - $24,574	1,018 New	1,018 $22,000

236

52.5M

10.2K

25.5K

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

Get notified when there are updates to the investment portfolio of Americana Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Americana Partners, LLC with notifications on news.